Sort
82,697 grants matching “vaccine development”
UPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)
$1,399,411Brad R Weiner · University Of Puerto Rico Med Sciences · U54 · FY2021 · CA
Highly multiplexed platforms for diagnosis of infection and immunity
$1,398,926W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2015 · AI
Development of a Universal Influenza Vaccine
$1,398,670Frank R. Jones · Etubics Corporation · R01 · FY2014 · AI
Vaccines to counter emerging antibiotic resistance
$1,398,346Wendy L Picking · University Of Kansas Lawrence · R01 · FY2018 · AI
Administrative Core and Data Management Center
$1,398,149Henry M Blumberg · Emory University · U19 · FY2020 · AI
SEQUENCING 12 MB OF THE SCHISTOSOMA MANSONI GENOME
$1,397,947Institute For Genomic Research · U01 · FY2001 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$1,397,944Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Production of Research Cell Banks
$1,397,939Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Medical Scientist Training Program
$1,397,835Christopher S. Williams · Vanderbilt University · T32 · FY2021 · GM
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES
$1,397,685Karen Kotloff · University Of Maryland Baltimore · N01 · FY2017 · AI
Early Life Vaccination to Prevent HIV acquisition during Adolescence
$1,397,532Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,397,389Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2008 · AI
Enhancing evidence generation by linking randomized clinical trials (RCTs) to real world data (RWD)
$1,397,144Elisabetta Patorno · Brigham And Women'S Hospital · U01 · FY2022 · FD
UC Davis/NIH NeuroMab Facility
$1,396,772James S Trimmer · University Of California At Davis · U24 · FY2012 · NS
Heat Shock Protein and Thermal Therapy of Cancer
$1,396,711John R. Subjeck · Roswell Park Cancer Institute Corp · P01 · FY2006 · CA
Core-001
$1,396,395Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2023 · AI
Heat Shock Protein and Thermal Therapy of Cancer
$1,396,380John R. Subjeck · Roswell Park Cancer Institute Corp · P01 · FY2007 · CA
Project 1: Characterization of the Antibody Response to SARS-CoV-2 in Lung Cancer Patients
$1,396,346Florian Krammer · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.
$1,396,158Robert Olmsted · Alphavax Human Vaccines, Inc. · U01 · FY2009 · AI
Viral Genomics: evolution, spread, and host interactions
$1,396,092Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2018 · AI
Development of an H2O2-Inactivated Dengue Virus Vaccine
$1,395,722Mark K Slifka · Oregon Health & Science University · R01 · FY2016 · AI
Production Development
$1,395,617Niranjan Y Sardesai · University Of Pennsylvania · U19 · FY2015 · AI
UC Davis/NIH NeuroMab Facility
$1,394,852James S Trimmer · University Of California At Davis · U24 · FY2011 · NS
Multicomponent vaccines for Pseudomonas aeruginosa
$1,394,646Gregory P Priebe · Boston Children'S Hospital · U19 · FY2025 · AI
Immunity to Pneumonic Tularemia
$1,394,480Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI